Literature DB >> 916025

Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses.

E F Fritsch, H M Temin.   

Abstract

Previously, we reported (Fritsch and Temin, J. Virol. 21:119-130, 1977) that infectious viral DNA was not present in spleen necrosis virus-infected stationary chicken cells. However, a stable intermediate was present in such infected stationary cells as evidenced by the appearance of infectious viral DNA shortly after serum stimulation of these cells. After serum stimulation of infected stationary cells, the infectious viral DNA appeared first in the nucleus. In contrast, in infected dividing cells the infectious viral DNA appeared first in the cytoplasm. Significantly reduced amounts of complete plus- or minus-strand viral DNAs were detected by nucleic acid hybridization in stationary chicken cells infected with spleen necrosis virus or Schmidt-Ruppin Rous sarcoma virus compared with the amounts detected in infected dividing cells. These experiments indicated that infected stationary cells did not contain complete noninfectious copies of viral DNA. Furthermore, 5-bromodeoxyuridine labeling and cesium chloride density gradient centrifugation analysis of the infectious viral DNA that appeared after serum stimulation of infected stationary cells indicated that most viral DNA synthesis occurred after addition of fresh serum.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 916025      PMCID: PMC515955     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Replication of reticuloendotheliosis viruses in cell culture: chronic infection.

Authors:  H M Temin; V K Kassner
Journal:  J Gen Virol       Date:  1975-06       Impact factor: 3.891

2.  Cell cycle-dependent activation of rous sarcoma virus-infected stationary chicken cells: avian leukosis virus group-specific antigens and ribonucleic acid.

Authors:  E H Humphries; H M Temin
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

3.  Light inactivation of focus formation by chicken embryo fibroblasts infected with avian sarcoma virus in the presence of 5-bromodeoxyuridine.

Authors:  D Boettiger; H M Temin
Journal:  Nature       Date:  1970-11-14       Impact factor: 49.962

4.  Nucleotide pool levels in growing, inhibited, and transformed chick fibroblast cells.

Authors:  C Colby; G Edlin
Journal:  Biochemistry       Date:  1970-02-17       Impact factor: 3.162

5.  Carcinogenesis by avian sarcoma viruses.

Authors:  H M Temin
Journal:  Cancer Res       Date:  1968-09       Impact factor: 12.701

6.  Formation and structure of infectious DNA of spleen necrosis virus.

Authors:  E Fritsch; H M Temin
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

7.  Lack of sequence homology among RNAs of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken endogenous RNA-directed DNA polymerase activity.

Authors:  C Y Kang; H M Temin
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

8.  Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA.

Authors:  E H Humphries; H M Temin
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

9.  Mechanism of oncogenic transformation by Rous sarcoma virus. I. Intracellular inactivation of cell-transforming ability of Rous sarcoma virus by 5-bromodeoxyuridine and light.

Authors:  P Balduzzi; H R Morgan
Journal:  J Virol       Date:  1970-04       Impact factor: 5.103

10.  Evidence for a stable intermediate in leukemia virus activation in AKR mouse embryo cells.

Authors:  J N Ihle; F T Kenney; R W Tennant
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  32 in total

1.  Restricting expression prolongs expression of foreign genes introduced into animals by retroviruses.

Authors:  V B Pinto; S Prasad; J Yewdell; J Bennink; S H Hughes
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.

Authors:  Grant Trobridge; David W Russell
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

3.  Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours.

Authors:  S T Andreadis; D Brott; A O Fuller; B O Palsson
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.

Authors:  D G Miller; M A Adam; A D Miller
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

5.  Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of the cell cycle.

Authors:  N A Kootstra; B M Zwart; H Schuitemaker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 6.  Avian retroviral replication.

Authors:  James Justice; Karen L Beemon
Journal:  Curr Opin Virol       Date:  2013-09-04       Impact factor: 7.090

7.  Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent.

Authors:  G M Springett; R C Moen; S Anderson; R M Blaese; W F Anderson
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

8.  Host factors that affect Ty3 retrotransposition in Saccharomyces cerevisiae.

Authors:  Michael Aye; Becky Irwin; Nadejda Beliakova-Bethell; Eric Chen; Jennifer Garrus; Suzanne Sandmeyer
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

9.  Ty3 transposes in mating populations of yeast: a novel transposition assay for Ty3.

Authors:  P T Kinsey; S B Sandmeyer
Journal:  Genetics       Date:  1995-01       Impact factor: 4.562

10.  Expression of transduced genes in mice generated by infecting blastocysts with avian leukosis virus-based retroviral vectors.

Authors:  M J Federspiel; D A Swing; B Eagleson; S W Reid; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.